View Author
patient cancer study analysis tumor sarcoma osteochondroma tissue factor expression mutation treatment survival group result cytology prognostic deletion doxorubicin stromal tumors table tumours staining stromal ext 1 disease lymphopenia tumour ext 1 gene response diagnosis cartilage cap tissue sarcoma grade ifosfamide bone sarcoma group chromosome research nonhereditary osteochondromas trial cohort chemotherapy sample liquid-based model antibody cycle european screening imatinib cd 117 progression-free survival therapy histological liquid-based cytology nonhereditary number clone prognostic factors article lch cells genomic langerhans cell histiocytosis lymphocyte lesion level metastase metastatic cd 1a region count protein cartilage department european organization pathology status biopsy university signi
8 Most Recent Publications
|
DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours
(Article)
Novelli, M. Rossi, S. Rodriguez-Justo, M. Taniere, P. Seddon, B. Toffolatti, L. Sartor, C. Hogendoorn, P.C.W. |
2010-08-01
|
|
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas. An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
(Article)
Sleijfer, S. Ouali, M. Glabbeke, M.M.B. van Krarup-Hansen, A. Rodenhuis, S. Cesne, A. le Hogendoorn, P.C.W. Verweij, J. Blay, J-Y. |
2010-01-01
|
|
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
(Article)
Ray-Coquard, I. Cropet, C. Guastalla, J.P. Bachelot, T. Perol, D. Chabaud, S. Hogendoorn, P.C.W. Cassier, P. Dufresne, A. Blay, J-Y. Glabbeke, M.M.B. van Sebban, C. Cesne, A. le Judson, I.R. Tredan, O. Verweij, J. Biron, P. Labidi, I. |
2009-07-01
|
|
Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors
(Article)
Romeo, S. Debiec-Rychter, M. Sciot, R. Blay, J-Y. Hogendoorn, P.C.W. Glabbeke, M.M.B. van Paassen, H. van Comite, P. Eijk, R. van Oosting, J. Verweij, J. Terrier, P. Schneider, U. |
2009-06-15
|
|
No genomic aberrations in langerhans cell histiocytosis as assessed by diverse molecular technologies
(Article)
Costa, C.E.T. da Szuhai, K. Maarten Egeler, R. Annels, N.E. Eijk, R. van Hoogeboom, M. Sciot, R. Mertens, F. Björgvinsdóttir, H. Debiec-Rychter, M. Krijger, R.R. de Hogendoorn, P.C.W. |
2009-03-01
|
|
Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program
(Article)
Beerman, H. Dorst, E.B. van Kuenen-Boumeester, V. Hogendoorn, P.C.W. |
2009-03-01
|
|
The role of EXT1 in nonhereditary osteochondroma: Identification of homozygous deletions
(Article)
Hameetman, L. Szuhai, K. Yavas, A. Knijnenburg, J. Duin, M. van Dekken, H. van Taminiau, A.H.M. Cleton-Jansen, A. Bovée, J.V.M.G. Hogendoorn, P.C.W. |
2007-03-07
|
|
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
(Article)
Leahy, M. Ray-Coquard, I. Judson, I.R. Blay, J-Y. Verweij, J. Cesne, A. le Duffaud, F. Hogendoorn, P.C.W. Fowst, C. Balincourt, C. de Paola, E.D. di Glabbeke, M.M.B. van |
2007-01-01
|
